[{"id":"93d8c998-c05e-429c-9692-227cbaba07cb","acronym":"NK4AML","url":"https://clinicaltrials.gov/study/NCT04347616","created_at":"2021-01-18T21:02:03.736Z","updated_at":"2024-07-02T16:35:08.070Z","phase":"Phase 1/2","brief_title":"Natural Killer-cell Therapy for Acute Myeloid Leukemia","source_id_and_acronym":"NCT04347616 - NK4AML","lead_sponsor":"Radboud University Medical Center","biomarkers":" IL2","pipe":"","alterations":" ","tags":["IL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • Proleukin (aldesleukin) • oNKord (inaleucel)"],"overall_status":"Recruiting","enrollment":" Enrollment 23","initiation":"Initiation: 12/03/2020","start_date":" 12/03/2020","primary_txt":" Primary completion: 09/01/2025","primary_completion_date":" 09/01/2025","study_txt":" Completion: 09/01/2025","study_completion_date":" 09/01/2025","last_update_posted":"2024-04-23"},{"id":"d7ab4f1f-8d2e-4ae2-8ca2-dd980d74c813","acronym":"INTRO","url":"https://clinicaltrials.gov/study/NCT03539406","created_at":"2021-01-18T17:26:19.590Z","updated_at":"2024-07-02T16:36:01.639Z","phase":"Phase 1","brief_title":"Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients","source_id_and_acronym":"NCT03539406 - INTRO","lead_sponsor":"Radboud University Medical Center","biomarkers":" MUC16","pipe":"","alterations":" ","tags":["MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e oNKord (inaleucel)"],"overall_status":"Recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 06/04/2019","start_date":" 06/04/2019","primary_txt":" Primary completion: 05/01/2023","primary_completion_date":" 05/01/2023","study_txt":" Completion: 10/01/2023","study_completion_date":" 10/01/2023","last_update_posted":"2022-10-28"}]